Pharmaceutical International News Archives - September 2011

Subscribe to Suppliers

Week 3 - September 2011

TB Drug Resistance

New Drug Plan Addresses Rising TB Resistance

Posted by Pharmaceutical International's Senior Journalist on 16:30:00

WHO unveils action plan to counter sharp spike in new drug-resistant tuberculosis cases being reported across Europe

Week 5 - September 2011

 Alpha Radiation Cancer Drug

Radium-223 Alpha Radiation Drug Excels in Trials

Posted by Pharmaceutical International's Drug Development Correspondent on 16:15:00

A cancer drug clinical trial has been stopped ahead of schedule as a result of the drug's exceptional performance

Nitisinone Albino Eyesight Treatment

Nitisinone is Potential Albino Eyesight Treatment

Posted by Pharmaceutical International's Senior Journalist on 14:25:00

Drug previously approved by US regulators to treat blood disorder might be beneficial to certain percentage of albino people

Cervical Cancer Vaccine Study

Cervical Cancer Vaccine Cervarix Studied

Posted by Pharmaceutical International's Senior Journalist on 12:25:00

British girls might not be getting the most cost-effective cervical cancer preventative, according to the Health Protection Agency

Cytisine Drug Trial

Low-Cost Anti-Smoking Drug Cytisine Trialled

Posted by Pharmaceutical International's Senior Journalist on 11:30:00

First major study into benefits of anti-smoking drug cytisine has concluded that millions of smokers could benefit from being on it